These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 6461675)
1. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review. Brazzell RK; Colburn WA J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):643-51. PubMed ID: 6461675 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of the retinoids. Lucek RW; Colburn WA Clin Pharmacokinet; 1985; 10(1):38-62. PubMed ID: 3882304 [TBL] [Abstract][Full Text] [Related]
3. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice. Berne B; Rollman O; Vahlquist A Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of isotretinoin during repetitive dosing to patients. Brazzell RK; Vane FM; Ehmann CW; Colburn WA Eur J Clin Pharmacol; 1983; 24(5):695-702. PubMed ID: 6575917 [TBL] [Abstract][Full Text] [Related]
5. The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol. Grønhøj Larsen F; Jakobsen P; Grønhøj Larsen C; Heidenheim M; Held E; Nielsen-Kudsk F Br J Dermatol; 2009 Sep; 161(3):664-70. PubMed ID: 19563582 [TBL] [Abstract][Full Text] [Related]
6. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats. Chien DS; Sandri RB; Tang-Liu DS Drug Metab Dispos; 1992; 20(2):211-7. PubMed ID: 1352212 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of isotretinoin and its major blood metabolite following a single oral dose to man. Colburn WA; Vane FM; Shorter HJ Eur J Clin Pharmacol; 1983; 24(5):689-94. PubMed ID: 6575916 [TBL] [Abstract][Full Text] [Related]
8. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. Goldstein JA; Socha-Szott A; Thomsen RJ; Pochi PE; Shalita AR; Strauss JS J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):760-5. PubMed ID: 6461679 [TBL] [Abstract][Full Text] [Related]
9. [Oral treatment with retinoids-mechanisms of action and clinical experiences in erythematosquamous and other dermatoses]. Hoting E; Maurach R; Meigel W Z Hautkr; 1982 Aug; 57(15):1137-43. PubMed ID: 6214899 [TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety. Nulman I; Berkovitch M; Klein J; Pastuszak A; Lester RS; Shear N; Koren G J Clin Pharmacol; 1998 Oct; 38(10):926-30. PubMed ID: 9807973 [TBL] [Abstract][Full Text] [Related]
11. Actions of isotretinoin and etretinate on the pilosebaceous unit. Gomez EC J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):746-50. PubMed ID: 6950956 [TBL] [Abstract][Full Text] [Related]
12. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies. Brouwer KR; McNamara PJ Drug Metab Dispos; 1989; 17(6):652-5. PubMed ID: 2575502 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of etretinate and its metabolites in the dog. Thongnopnua P; Massarella JW; Zimmerman CL Drug Metab Dispos; 1989; 17(5):473-80. PubMed ID: 2573489 [TBL] [Abstract][Full Text] [Related]
14. The negligible systemic availability of retinoids with multiple and excessive topical application of isotretinoin 0.05% gel (Isotrex) in patients with acne vulgaris. Jensen BK; McGann LA; Kachevsky V; Franz TJ J Am Acad Dermatol; 1991 Mar; 24(3):425-8. PubMed ID: 1829464 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography. Jakobsen P; Larsen FG; Larsen CG J Chromatogr; 1987 Apr; 415(2):413-8. PubMed ID: 2953748 [No Abstract] [Full Text] [Related]
16. Monitoring of isotretinoin therapy by measuring the plasma levels of isotretinoin and 4-oxo-isotretinoin. A useful tool for management of severe acne. Almond-Roesler B; Blume-Peytavi U; Bisson S; Krahn M; Rohloff E; Orfanos CE Dermatology; 1998; 196(1):176-81. PubMed ID: 9557257 [TBL] [Abstract][Full Text] [Related]
17. Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: drug and vitamin A concentrations in serum and skin. Rollman O; Vahlquist A J Invest Dermatol; 1986 Apr; 86(4):384-9. PubMed ID: 2943822 [TBL] [Abstract][Full Text] [Related]
18. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients. Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917 [TBL] [Abstract][Full Text] [Related]
19. Oral retinoids in the treatment of seborrhoea and acne. Orfanos CE; Zouboulis CC Dermatology; 1998; 196(1):140-7. PubMed ID: 9557249 [TBL] [Abstract][Full Text] [Related]
20. The retinoids. A review of their clinical pharmacology and therapeutic use. Orfanos CE; Ehlert R; Gollnick H Drugs; 1987 Oct; 34(4):459-503. PubMed ID: 3315625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]